Adagene  logo
Adagene ADAG
$ 3.26 0.62%

Annual report 2024
added 02-21-2026

report update icon

Adagene Interest Expense 2011-2026 | ADAG

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.
Includes:
  • Interest on bank loans
  • Interest on corporate bonds
  • Interest on leases
  • Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Adagene

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- 1.11 M 693 K 364 K 202 K 138 K 91.1 K - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.11 M 91.1 K 433 K

Interest Expense of other stocks in the Biotechnology industry

Issuer Interest Expense Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
4.66 M - 2.43 % $ 254 M germanyGermany
ARCA biopharma ARCA biopharma
ABIO
9 K - 1052.0 % $ 415 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
9.29 M $ 1.68 2.44 % $ 429 M britainBritain
Acer Therapeutics Acer Therapeutics
ACER
432 K - 2.71 % $ 14 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
8.23 M - - $ 86.2 M usaUSA
I-Mab I-Mab
IMAB
722 K - - $ 866 M chinaChina
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
29.5 M - - $ 1.01 B usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
2.28 K $ 3.28 -2.62 % $ 7.89 B australiaAustralia
Akero Therapeutics Akero Therapeutics
AKRO
4.67 M - - $ 3.67 B usaUSA
Akouos Akouos
AKUS
-1.72 M - 0.23 % $ 488 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
3.69 M - -0.23 % $ 916 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
476 K - - $ 2.17 B usaUSA
AlloVir AlloVir
ALVR
1.19 M - 4.14 % $ 49.1 M usaUSA
XTL Biopharmaceuticals Ltd. XTL Biopharmaceuticals Ltd.
XTLB
28 K $ 0.88 -1.43 % $ 442 M israelIsrael
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
-38 K - 3.16 % $ 1.9 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
-5.01 K - -11.43 % $ 502 K usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
31.5 M - -24.86 % $ 820 K usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
-4 K - - $ 10.1 M usaUSA
Aravive Aravive
ARAV
2.84 M - -13.39 % $ 1.45 M usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
80.6 M $ 224.42 -2.52 % $ 5 B danmarkDanmark
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
2.67 M - - $ 26.5 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
4.16 M - -6.81 % $ 3.04 B usaUSA
Athersys Athersys
ATHX
103 K - 3.77 % $ 22.4 M usaUSA
Anavex Life Sciences Corp. Anavex Life Sciences Corp.
AVXL
4.68 M $ 4.13 0.12 % $ 352 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
4.9 M - -10.17 % $ 12.2 K usaUSA
Aytu BioScience Aytu BioScience
AYTU
-512 K $ 2.36 2.27 % $ 14.8 M usaUSA
Aptinyx Aptinyx
APTX
737 K - -39.0 % $ 4.57 M usaUSA
Brickell Biotech Brickell Biotech
BBI
5 K - -5.38 % $ 6.06 M usaUSA
Codexis Codexis
CDXS
-10.4 M $ 1.17 -0.85 % $ 85.9 M usaUSA
Athira Pharma Athira Pharma
ATHA
3.96 M - - $ 269 M usaUSA
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
11.8 M $ 14.49 -0.75 % $ 4.48 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
-5.79 M - 1.93 % $ 17.4 M usaUSA